Page 116 - 《中国药房》2024年22期
P. 116

ZHANG  Z  F.  Clinical  observation  on  mycophenolate   2022,32(6):75-77.
               mofetil  combined  with  hormone  in  the  treatment  of  27   GAO G. The therapeutic effect of mycophenolate mofetil
               cases of nephrotic syndrome purpura nephritis[J]. Shanxi   and  methylprednisolone  double  shock  therapy  combined
               Med J,2006,35(1):66-67.                             with DFPPD on children with HSPN[J]. J Shanxi Health
          [21]  刘大军,杜威,刘葵. 来氟米特治疗过敏性紫癜肾炎的临                         Vocat Coll,2022,32(6):75-77.
               床观察[J]. 中国现代医学杂志,2012,22(15):57-61.            [29]  王一冰,李强,李晶,等 . 来氟米特与环磷酰胺治疗
               LIU D J,DU W,LIU K. Clinical observation of the effect   HSPN效果比较[J].齐鲁医学杂志,2009,24(5):424-426.
               of  leflunomide  on  purpuric  nephritis  nephrotic  syndrome  WANG Y B,LI Q,LI J,et al. Leflunomide and cyclopho-
               [J]. China J Mod Med,2012,22(15):57-61.             sphamide:a  comparison  of  their  efficacy  for  Henoch-
          [22]  孙剑,张浩,刘纪实,等. 来氟米特与霉酚酸酯治疗表现                         Schönlein purpura nephritis[J]. Med J Qilu,2009,24(5):
               为肾病综合征的过敏紫癜性肾炎的疗效比较[J]. 中国中                         424-426.
               西医结合肾病杂志,2008,9(8):691-693.                    [30]  杨磊,郭明好,刘云. 来氟米特治疗肾病综合征表现的紫
               SUN J,ZHANG H,LIU J S,et al. Comparison between     癜肾临床观察[J]. 现代泌尿外科杂志,2009,14(5):
               leflunomide  and  mycophenolate  mofetil  treatment  in  ne‐  353-355.
               phropathy  syndrome  caused  by  Henoch-Schönlein  pur‐  YANG L,GUO M H,LIU Y. Leflunomide in treating pur‐
               pura nephritis[J]. Chin J Integr Tradit West Nephrol,2008,  pura  nephritis  with  nephritic  syndrome[J].  J  Mod  Urol,
               9(8):691-693.                                       2009,14(5):353-355.
          [23]  白玲,马兰红,麦迪娜,等. 环孢素A 联合甲泼尼龙冲击                   [31]  邢二庆,刘玉霞,尚家星. 甲泼尼龙+环磷酰胺冲击治疗
               治疗重症紫癜性肾炎患儿的疗效及对蛋白尿、VCAM-1                          联合双重血浆置换在重症紫癜性肾炎患儿中的应用观
               和VEGF的影响[J]. 西部医学,2021,33(5):693-696,700.           察[J]. 中国医学工程,2021,29(6):113-116.
               BAI L,MA L H,MAI D N,et al. The efficacy of cyclo‐  XING E Q,LIU Y X,SHANG J X. Observation on the ap‐
               sporine A combined with methylprednisolone in the treat‐  plication  of  methylprednisolone+cyclophosphamide  pulse
               ment  of  children  with  severe  purpuric  nephritis  and  its      therapy  combined  with  double  plasma  exchange  in  chil‐
               effect on proteinuria,VCAM-1 and VEGF[J]. Med J West   dren with severe purple epilepsy nephritis[J]. China Med
               China,2021,33(5):693-696,700.                       Eng,2021,29(6):113-116.
          [24]  宣萍. 205例成人过敏性紫癜性肾炎的临床特征与治疗                    [32]  中华医学会儿科学分会肾脏学组.紫癜性肾炎诊治循证
               分析[D]. 杭州:浙江大学,2014.                                指南:2016[J].中华儿科杂志,2017,55(9):647-651.
               XUAN  P.  Clinical  characteristics  and  treatment  of  205   Subspecialty Group of Renal Diseases,the Society of
               cases  of  adult  Henoch-Schönlein  purpura  nephritis[D].  Pediatrics,Chinese  Medical Association.  Evidence-based
               Hangzhou:Zhejiang University,2014.                  guideline  for  diagnosis  and  treatment  of  Henoch-
          [25]  耿海云,陈朝英,李华荣,等. 霉酚酸酯和环磷酰胺治疗                         Schönlein purpura nephritis:2016[J]. Zhonghua Er Ke Za
               儿童大量蛋白尿型过敏性紫癜性肾炎的前瞻性随机对                             Zhi,2017,55(9):647-651.
               照研究[J]. 中国当代儿科杂志,2021,23(4):338-342.           [33]  WU D Y,MA R,WANG X M,et al. Efficacy and safety
               GENG H Y,CHEN C Y,LI H R,et al. Efficacy and safety   of  tacrolimus  in  the  treatment  of  pediatric  Henoch-
               of mycophenolate mofetil versus cyclophosphamide in the   Schönlein  purpura  nephritis[J].  Paediatr  Drugs,2022,24
               treatment  of  Henoch-Schönlein  purpura  nephritis  with   (4):389-401.
               nephrotic-range proteinuria in children:a prospective ran‐  [34]  HOU L,ZHANG Z,DU Y. Leflunomide therapy for IgA
               domized  controlled  trial[J].  Chin  J  Contemp  Pediatr,  vasculitis  with  nephritis  in  children[J].  BMC  Pediatr,
               2021,23(4):338-342.                                 2021,21(1):391.
          [26]  陈金花,郭雨,覃琳. 他克莫司与环磷酰胺分别联合激素                    [35]  KAWASAKI  Y,SUYAMA  K,HASHIMOTO  K,et  al.
               治疗小儿Ⅲ~Ⅳ级紫癜性肾炎的对比研究[J]. 中国中西                         Methylprednisolone  pulse  plus  mizoribine  in  children
               医结合肾病杂志,2022,23(8):728-730.                         with  Henoch-Schönlein  purpura  nephritis[J].  Clin  Rheu‐
               CHEN J H,GUO Y,QIN L. Comparative study of tacroli‐  matol,2011,30(4):529-535.
               mus  and  cyclophosphamide  combined  with  hormone  in   [36]  NGUYEN B,ACHARYA C,TANGPANITHANDEE S,et
               the  treatment  of  grade  Ⅲ - Ⅳ  Henoch-Schönlein  purpura   al. Efficacy and safety of plasma exchange as an adjunc‐
               nephritis  in  children[J].  Chin  J  Integr  Tradit  West   tive therapy for rapidly progressive IgA nephropathy and
               Nephrol,2022,23(8):728-730.                         Henoch-Schönlein  purpura  nephritis:a  systematic  review
          [27]  吴登艳. 他克莫司治疗儿童过敏性紫癜性肾炎的有效性                          [J]. Int J Mol Sci,2023,24(4):3977.
               及安全性研究[D]. 兰州:兰州大学,2021.                       [37]  KAWASAKI  Y,SUYAMA  K,MATSUMOTO  A,et  al.
               WU  D Y.  Efficacy  and  safety  of  tacrolimus  in  the  treat‐  Efficacy  of  tonsillectomy  plus  methylprednisolone  pulse
               ment  of  Henoch-Schönlein  purpura  nephritis  in  children  therapy for a child with Henoch-Schönlein purpura nephri‐
               [D]. Lanzhou:Lanzhou University,2021.               tis[J]. Tohoku J Exp Med,2007,211(3):291-295.
          [28]  高罡 . 霉酚酸酯+甲泼尼龙双冲击疗法联合 DFPPD 对                               (收稿日期:2024-07-02  修回日期:2024-10-25)
               HSPN 患儿的疗效[J]. 山西卫生健康职业学院学报,                                                       (编辑:陈 宏)



          · 2814 ·    China Pharmacy  2024 Vol. 35  No. 22                            中国药房  2024年第35卷第22期
   111   112   113   114   115   116   117   118   119   120   121